Research Alliance Corp. I... (RACB)
NASDAQ: RACB
· Real-Time Price · USD
10.11
0.00 (0.05%)
At close: Dec 01, 2022, 9:46 PM
Company Description
Research Alliance Corp.
II does not have significant operations.
The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
It identifies and acquires a business, focusing on the healthcare industry, such as in biotechnology sector.
Research Alliance Corp.
II was incorporated in 2020 and is based in Las Vegas, Nevada.
Research Alliance Corp. II
| Country | United States |
| IPO Date | Mar 18, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | n/a |
Contact Details
Address: 3172 North Rainbow Boulevard Las Vegas, Nevada United States | |
| Website | https://www.researchalliancecorpii.com |
Stock Details
| Ticker Symbol | RACB |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001819724 |
| CUSIP Number | |
| ISIN Number | US7608731094 |
| Employer ID | 85-2019822 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Dr. Peter Kolchinsky Ph.D. | Co-Founder, Chairman & Chief Executive Officer |
| Theresa Cameron | Co-Founder & Chief Financial Officer |
| Dr. Matthew Hammond M.B.A., Ph.D. | Co-Founder, Chief Investment Officer, Sec. & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 14, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 08, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jan 10, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Dec 16, 2022 | 15-12G | Filing |
| Dec 06, 2022 | 25-NSE | Filing |
| Dec 06, 2022 | 8-K | Current Report |
| Nov 28, 2022 | DEFA14A | Filing |